A carregar...
Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice
Lysophosphatidic acid (LPA), a bioactive lysophospholipid, is involved in the pathogenesis of chronic inflammatory and autoimmune diseases. In this study, we investigated the role of LPA/LPA receptor (LPAR) signaling in the pathogenesis of Sjögren's syndrome (SS). We found that autotaxin, an LP...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5432331/ https://ncbi.nlm.nih.gov/pubmed/28460477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15916 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|